CIK 0001853816 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858)-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-21 | PROEHL GERALD T President, CEO and Chairman | Grant or award | +787,402 | 799,508 | ||
| 2025-01-21 | PROEHL GERALD T President, CEO and Chairman | Grant or award · Warrant (Right to Buy) | +787,402 | 787,402 | ||
| 2025-01-21 | HALE DAVID F Director | Grant or award · Warrant (Right to Buy) | +78,741 | 78,741 | ||
| 2025-01-13 | Sandler Andrew Seth Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-01-13 | Nardo Christopher J. Senior VP, CDO | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-01-13 | Bradrick Brittany Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-01-13 | Bedoya-Toro Munera Maria E SVP, Regulatory Affairs | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2025-01-13 | HALE DAVID F Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-01-13 | WIERENGA WENDELL Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-01-13 | FISHER MARY Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-01-13 | Van Hoose Kyri K. SVP, CFO | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-01-13 | PROEHL GERALD T President, CEO and Chairman | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2025-01-13 | Mento Steven J Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-01-13 | Scott Kathleen D. Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-01-04 | Mento Steven J Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-01-04 | PROEHL GERALD T President, CEO and Chairman | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-01-04 | FISHER MARY Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-01-04 | Scott Kathleen D. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-01-04 | Sandler Andrew Seth Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-01-04 | Nardo Christopher J. Senior VP, CDO | Grant or award · Stock Option (right to buy | +50,000 | 50,000 |
Page 3 of 9 · 172 trades